IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Apr 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AKCEA THERAPEUTICS, INC. (AKCA)
CIK: 0001662524
Period of Report: 2019-03-29

Reporting Person: IONIS PHARMACEUTICALS INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-29	Common Stock	J	2837373	—	Acquired	70221338	Direct

Footnotes

F1: Shares issued in satisfaction of the Issuer's obligations to the Reporting Person pursuant to that certain Development, Commercialization and License Agreement, dated December 18, 2015, between the Issuer and the Reporting Person.